PRELUDE CAPITAL MANAGEMENT, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1387508
NEW YORK, NY
Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,883,822
+$2,472,903 QoQ
Shares Held
5,752
+588.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,032
of 2,619 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Derivatives in TMO
reported options exposure · as of Mar 31, 2021CallValue
$0
CallShares
0
PutValue
$319,466
PutShares
700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $9,382,081 across 8 Diagnostics & Research names. TMO ranks #2 (30.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SHC |
Sotera Health Co
|
208,430 | $3,699,632 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
5,752 | $2,883,822 | |
| 3 | FLGT |
Fulgent Genetics, Inc.
|
51,698 | $1,060,842 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
809 | $425,889 | |
| 5 | DHR |
Danaher Corp /De/
|
2,072 | $394,674 | |
| 6 | NTRA |
Natera, Inc.
|
1,428 | $387,630 | |
| 7 | LH |
Labcorp Holdings Inc.
|
1,130 | $316,400 | |
| 8 | GH |
Guardant Health, Inc.
|
1,421 | $213,192 |
All Filings in TMO
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,883,822 | 5,752 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $410,919 | 836 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $960,728 | 1,658 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $269,671 | 556 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $226,246 | 558 | Shares | Other | 2025-08-14 | |
| 2024-09-30 | $215,880 | 349 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $362,215 | 655 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $305,716 | 526 | Shares | Other | 2024-05-15 | |
| 2023-09-30 | $1,951,791 | 3,856 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $1,286,635 | 2,466 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $248,991 | 432 | Shares | Other | 2023-06-01 | |
| 2022-12-31 | $259,374 | 471 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $597,469 | 1,178 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $513,399 | 945 | Shares | Other | 2022-08-24 | |
| 2022-03-31 | $2,357,874 | 3,992 | Shares | Other | 2022-05-16 | |
| 2021-09-30 | $1,175,797 | 2,058 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $685,574 | 1,359 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $319,466 | 700 | Put | Other | 2021-05-17 | |
| 2020-09-30 | $211,488 | 479 | Shares | Other | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||